---
title: "EQ: EQ504 targets UC with a novel, validated approach, backed by strong science and financial runway"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295857504.md"
description: "EQ504, a highly potent and selective oral AhR modulator, is advancing as a colon-targeted therapy for ulcerative colitis, addressing a large unmet need in a $12B+ global market. Strong preclinical and clinical validation, robust IP, and a solid financial position support progress toward key milestones, with Phase 1 initiation expected in Q4 2026.Original document: Equillium, Inc. [EQ] Slides Release — Aug. 13 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-13T23:14:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295857504.md)
  - [en](https://longbridge.com/en/news/295857504.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295857504.md)
generator: "portal-rs"
---

# EQ: EQ504 targets UC with a novel, validated approach, backed by strong science and financial runway

EQ504, a highly potent and selective oral AhR modulator, is advancing as a colon-targeted therapy for ulcerative colitis, addressing a large unmet need in a $12B+ global market. Strong preclinical and clinical validation, robust IP, and a solid financial position support progress toward key milestones, with Phase 1 initiation expected in Q4 2026.

Original document: Equillium, Inc. \[EQ\] Slides Release — Aug. 13 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [EQ.US](https://longbridge.com/en/quote/EQ.US.md)

## Related News & Research

- [09:22 ETAfecta Pharmaceuticals Granted New US Patent for Neuro-Immuno Modulators](https://longbridge.com/en/news/296921568.md)
- [What's Going On With Cerebras Stock on Monday?](https://longbridge.com/en/news/296782127.md)
- [09:45 ETFaceTec Issued New Patent by the USPTO](https://longbridge.com/en/news/296365720.md)
- [What's Going On With SU Group Stock Monday?](https://longbridge.com/en/news/296793641.md)
- [International extends SPAC deal deadline to Oct. 2, 2026 with $2,000 trust payment](https://longbridge.com/en/news/296826600.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**